CVTX - CV Therapeutics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	6/29/2005 12:30:29 PM
	Read Replies (1) of 411

CV Therapeutics 7.3M-Shr Secondary Prices At $21.60/Shr DOW JONES NEWSWIRES June 28, 2005 7:00 p.m. -- =- NEW YORK (Dow Jones)--CV Therapeutics Inc.'s (CVTX) 7.3 million-share secondary stock offering priced at $21.60 a share Tuesday evening. CV's offer, which was managed by Lehman Brothers and Merrill Lynch, had a gross spread of $1.19, a selling concession of 71 cents, and a management fee of about 24 cents. The underwriting fee was also about 24 cents, the reallowance was a dime, and the offer settles Friday. The biopharmaceutical company recently had 36 million shares outstanding. On Tuesday, CV's shares closed up 4.4%, or 92 cents, at $22.05.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next